ARYx Therapeutics Inc (ARYX)
0.00
USD |
OTCM |
May 21, 16:00
ARYx Therapeutics Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
December 30, 2009 | 46.94 |
December 29, 2009 | 44.36 |
December 28, 2009 | 44.06 |
December 24, 2009 | 42.23 |
December 23, 2009 | 40.87 |
December 22, 2009 | 39.50 |
December 21, 2009 | 38.28 |
December 18, 2009 | 36.31 |
December 17, 2009 | 36.61 |
December 16, 2009 | 37.98 |
December 15, 2009 | 36.76 |
December 14, 2009 | 39.80 |
December 11, 2009 | 40.71 |
December 10, 2009 | 39.80 |
December 09, 2009 | 40.41 |
December 08, 2009 | 41.17 |
December 07, 2009 | 40.41 |
December 04, 2009 | 41.78 |
December 03, 2009 | 39.80 |
December 02, 2009 | 41.62 |
December 01, 2009 | 39.80 |
November 30, 2009 | 37.83 |
November 27, 2009 | 41.17 |
November 25, 2009 | 42.69 |
November 24, 2009 | 37.98 |
Date | Value |
---|---|
November 23, 2009 | 37.52 |
November 20, 2009 | 37.37 |
November 19, 2009 | 36.92 |
November 18, 2009 | 37.52 |
November 17, 2009 | 37.98 |
November 16, 2009 | 37.83 |
November 13, 2009 | 36.31 |
November 12, 2009 | 35.70 |
November 11, 2009 | 37.07 |
November 10, 2009 | 38.74 |
November 09, 2009 | 37.98 |
November 06, 2009 | 39.65 |
November 05, 2009 | 37.68 |
November 04, 2009 | 36.46 |
November 03, 2009 | 35.55 |
November 02, 2009 | 36.76 |
October 30, 2009 | 37.82 |
October 29, 2009 | 34.79 |
October 28, 2009 | 34.79 |
October 27, 2009 | 36.00 |
October 26, 2009 | 36.76 |
October 23, 2009 | 39.48 |
October 22, 2009 | 41.60 |
October 21, 2009 | 40.39 |
October 20, 2009 | 41.60 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
NovaBay Pharmaceuticals Inc | -- |
Palatin Technologies Inc | 20.85 |
iBio Inc | 0.7735 |
Theriva Biologics Inc | 0.2081 |
Oragenics Inc | 11.46 |